BR9914617A - Composições de unguento em aerossol e método de fabricação - Google Patents

Composições de unguento em aerossol e método de fabricação

Info

Publication number
BR9914617A
BR9914617A BR9914617-7A BR9914617A BR9914617A BR 9914617 A BR9914617 A BR 9914617A BR 9914617 A BR9914617 A BR 9914617A BR 9914617 A BR9914617 A BR 9914617A
Authority
BR
Brazil
Prior art keywords
ointment
aerosol
composition
relief
tissue
Prior art date
Application number
BR9914617-7A
Other languages
English (en)
Inventor
Lloyd J Osipow
Dorothea C Marra
J George Spitzer
Original Assignee
Oms Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oms Holdings Llc filed Critical Oms Holdings Llc
Publication of BR9914617A publication Critical patent/BR9914617A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES DE UNGuENTO EM AEROSSOL E MéTODO DE FABRICAçãO". A presente invenção refere-se a composições de ung³ento em aerossol, em que quando um depósito é expelido de um recipiente de aerossol contendo a composição sobre o tecido lesionado, está aplicado ao tecido um ung³ento frio que exerce um efeito de alívio da dor por resfriamento e um efeito terapêutico do medicamento no tecido. Exemplos de ung³entos típicos são aqueles para alivio temporário de hemorróidas, tratamento de queimadura de sol e alivio da dor artrítica. é ainda propiciado um método para a fabricação de uma composição de ung³ento em aerossol que é capaz de expelir de um recipiente de aerossol um ung³ento que exerce, sobre tecidos lesionados, tanto um efeito refrigerante de alivio da dor como um efeito terapêutico medicinal. A composição em aerossol melhora a ação terapêutica de um ung³ento por produzir um efeito refrigerante constante que proporciona um rápido alívio da dor e coceira bem como uma tendência a encolher o tecido inflamado e intumescido antes da ação mais lenta de qualquer medicamento presente no ung³ento. A composição em aerossol consiste em de cerca de 10 a cerca de 60 porcento em peso de ingredientes de um ung³ento que é uma emulsão de óleo em água e de cerca de 40 a cerca de 90 porcento em peso de propelente liq³efeito que é predominantemente um propelente apolar. A soma dos ingredientes do ung³ento e do propelente perfaz 100 porcento em peso da composição.
BR9914617-7A 1998-10-19 1999-03-31 Composições de unguento em aerossol e método de fabricação BR9914617A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17485898A 1998-10-19 1998-10-19
US09/281,162 US6214318B1 (en) 1997-10-02 1999-03-30 Aerosol ointment compositions for topical use
PCT/US1999/007068 WO2000023051A1 (en) 1998-10-19 1999-03-31 Aerosol ointment compositions and method of manufacture

Publications (1)

Publication Number Publication Date
BR9914617A true BR9914617A (pt) 2002-01-02

Family

ID=26870607

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914617-7A BR9914617A (pt) 1998-10-19 1999-03-31 Composições de unguento em aerossol e método de fabricação

Country Status (9)

Country Link
US (1) US6214318B1 (pt)
EP (1) EP1121101A1 (pt)
JP (1) JP2003525857A (pt)
KR (1) KR20010089881A (pt)
CN (1) CN1167413C (pt)
AU (1) AU766944B2 (pt)
BR (1) BR9914617A (pt)
CA (1) CA2347108A1 (pt)
WO (1) WO2000023051A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6589922B1 (en) * 2001-03-08 2003-07-08 Dow Pharmaceutical Sciences Skin cleanser comprising a steareth, poloxamer, and a glyceryl monoester
US20020185426A1 (en) * 2001-04-26 2002-12-12 Bealer Leroy J. Environmental flexible remediation system
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
WO2004091554A1 (en) * 2003-04-14 2004-10-28 Taro Pharmaceuticals U.S.A., Inc. Process to prepare a skin softening composition
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
CN1279056C (zh) * 2003-06-06 2006-10-11 马菁 肿瘤相关抗原sm5－1的特异性抗体及其应用
US20050232926A1 (en) * 2003-06-06 2005-10-20 Oncomax Acquisition Corp. Antibodies specific for cancer associated antigen SM5-1 and uses thereof
JP4615198B2 (ja) * 2003-07-25 2011-01-19 久光製薬株式会社 抗真菌エアゾール外用製剤
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20050123484A1 (en) * 2003-10-02 2005-06-09 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
US20060004094A1 (en) * 2004-07-02 2006-01-05 Agisim Gary R Composition and method for treating hemorrhoids and/or anorectal disorders
US20060147484A1 (en) * 2005-01-03 2006-07-06 Hestand Mark A Urushiol-induced contact dermatitis composition, method of use, and method of manufacture
JP4863641B2 (ja) * 2005-03-31 2012-01-25 小林製薬株式会社 使用感及び高温安定性に優れた分散系痔疾治療用軟膏剤
US20070027153A1 (en) * 2005-07-27 2007-02-01 Reeth Kevin M Topical skin-protectant and anti-pruritic compositions
US20070066499A1 (en) * 2005-09-19 2007-03-22 Conopco, Inc., D/B/A Unilever Self-supporting aerosol cleansing composition
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
WO2012071251A1 (en) * 2010-11-24 2012-05-31 Pharmasol Corporation Aerosol emulsions
US9872832B2 (en) * 2015-10-23 2018-01-23 LG Bionano, LLC Nanoemulsions having reversible continuous and dispersed phases
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB998776A (en) 1962-08-11 1965-07-21 Cooper Mcdougall & Robertson Packed self-propelling compositions, containers therefor and the manufacture thereof
GB1123868A (en) 1965-09-08 1968-08-14 Philips Roxane Compositions for treating anal and perianal disorders
US3859432A (en) 1967-10-24 1975-01-07 Ben Dinerstein Method for soothing cooling and refreshing
US3970584A (en) 1973-02-14 1976-07-20 S. C. Johnson & Son, Inc. Aerosol package containing a foam-forming emulsion and propellent system
ZA77943B (en) 1976-03-19 1977-12-28 Upjohn Co Topical steroid clindamycin preparations
US4331653A (en) 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
US4439343A (en) 1979-07-23 1984-03-27 United Industries Corporation Aerosol preparation
US4422887A (en) 1980-09-10 1983-12-27 Imi Kynoch Limited Heat treatment
US4422877A (en) * 1980-10-28 1983-12-27 Restech Research Limited Partnership Synthetic polymer-propellant compositions forming cold foamed structures having a temperature at least 30° C. below ambient temperature and containing open and/or closed cells
US4716032A (en) 1983-08-03 1987-12-29 Geoffrey J. Westfall Aerosol spray composition for mastitis prevention
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
US5116618A (en) 1985-04-26 1992-05-26 S. C. Johnson & Son, Inc. Water-soluble arthropodicidally-active foam matrix and method of manufacture
US4981677A (en) 1987-09-23 1991-01-01 L'oreal Petrolatum-containing aerosol foam concentrate
US5143717A (en) 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
DE3810730A1 (de) 1988-03-30 1989-10-12 Desitin Arzneimittel Gmbh Spruehbare salbenzusammensetzung
JPH01301618A (ja) 1988-05-30 1989-12-05 Toyo Aerosol Kogyo Kk 冷却用エアゾール製品
DE69030698T2 (de) 1989-03-17 1997-10-02 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo Aerosolzusammensetzung zur äusserlichen verwendung
US5209921A (en) 1989-05-19 1993-05-11 Beecham Group Plc Aerosol compositions
US5098693A (en) 1989-07-21 1992-03-24 Cast Blast Anti-irritant spray for use with cast and method of application
DK0484530T3 (da) 1989-07-28 1995-08-21 Hisamitsu Pharmaceutical Co Opskummeligt aerosolpræparat
FR2662079B1 (fr) 1990-05-18 1993-11-05 Oreal Emulsion cosmetique filtrante comprenant un filtre uv-a et un filtre uv-b et son utilisation pour la protection de la peau contre les radiations ultraviolettes.
US5145604A (en) 1990-09-19 1992-09-08 S. C. Johnson & Son, Inc. Aqueous emulsion and aerosol delivery system using same
US5518712A (en) 1992-06-25 1996-05-21 Stewart; Ernest Water resistant sunscreen protection and insect repellent compound
US5618515A (en) 1992-08-19 1997-04-08 Blistex Inc. Aerosol spray composition for the treatment of dermal burns by cooling and anesthetizing the wound and valved container for dispensing same
DE4305788C2 (de) 1993-02-25 1997-06-12 Beiersdorf Ag Kosmetische und dermatologische Formulierungen zum Schutze der Haut gegen Oxidationsprozesse
DE4228455A1 (de) 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
DE4307983A1 (de) 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
US5443817A (en) 1993-08-23 1995-08-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Self-foaming cleanser
ATE204571T1 (de) 1993-11-23 2001-09-15 Ciba Sc Holding Ag O-hydroxyphenyl-s-triazine enthaltende stabilisierte polymere
DE4420625C1 (de) 1994-06-14 1995-11-02 Beiersdorf Ag Wirkstoffkombination mit einem Gehalt an Glycerylalkylethern und kosmetische und dermatologische Zubereitungen, solche Wirkstoffkombinationen enthaltend
GB9414699D0 (en) 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5490980A (en) * 1994-09-28 1996-02-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Covalent bonding of active agents to skin, hair or nails
FR2728265A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p dans une composition pharmaceutique
HUP9601442A3 (en) 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US5635165A (en) 1995-09-27 1997-06-03 Helene Curtis, Inc. Antiperspirant deodorant compositions
JP3658897B2 (ja) 1995-12-14 2005-06-08 大正製薬株式会社 エアゾール剤
US5718916A (en) 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products
CA2306484A1 (en) * 1997-10-02 1999-04-15 Omc Holdings, Llc Aerosol ointment compositions and method of manufacture

Also Published As

Publication number Publication date
AU766944B2 (en) 2003-10-30
CN1376055A (zh) 2002-10-23
JP2003525857A (ja) 2003-09-02
KR20010089881A (ko) 2001-10-12
AU3458399A (en) 2000-05-08
WO2000023051A1 (en) 2000-04-27
CN1167413C (zh) 2004-09-22
EP1121101A1 (en) 2001-08-08
CA2347108A1 (en) 2000-04-27
US6214318B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
BR9914617A (pt) Composições de unguento em aerossol e método de fabricação
AU2009331845B2 (en) Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
DE69733086T2 (de) Pharmazeutische zusammensetzungen welche kukui nuss öl enthalten
ES2206567T3 (es) Preparaciones externas para el tratamiento de dermatosis.
ES2310549T3 (es) Composiciones dermicas que contienen coenzima q como principio activo.
EP0129285A2 (en) Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl)pyrrolidone
AU2020325925A1 (en) Topical formulations comprising cannabidiol, method of preparing the composition and use thereof
US4654323A (en) Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
Federman et al. Topical psoriasis therapy
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
RU2233151C2 (ru) Применение тозилхлорамидов для лечения заболеваний кожи и слизистой оболочки
US4910197A (en) Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
US4777171A (en) Method and composition for the therapeutic and prophylactic treatment of trauma to the skin
AU2004264332B2 (en) Method and composition for treating burned skin
RU2132183C1 (ru) Мазь для лечения воспалительных и аллергических поражений кожи
AT504040B1 (de) Diclofenac-hältige zubereitung zur behandlung von verbrennungen
RU2138277C1 (ru) Средство для комплексного лечения ожоговых и постравматических ран
JP4499425B2 (ja) 経皮吸収促進剤および水虫治療用組成物
KR960706345A (ko) 건선 치료(Psoriasis treatment)
KR101954057B1 (ko) 피부에 적용될 수 있는 조성물 및 이의 용도
JP3187806B2 (ja) ニトロイミダゾール系化合物を含むアトピー性皮膚炎治療用の外用剤
UA82472C2 (uk) Трансдермальна фармацевтична композиція, що містить ацетилсаліцилову кислоту, для лікування кальцифікації
DE69821010D1 (de) Aerosol-salben-zubereitungen
US20200281876A1 (en) Topical Preparation for the Treatment of Arthritis and Skin Conditions

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A E 10A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1986 DE 07/01/2009.